Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2375
Abstract: The proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9-I), evolocumab, reduced the risk of cardiovascular event in patients with peripheral artery disease in FOURIER trial. However, the effects of evolocumab on favorable limb outcomes in patients… read more here.
Keywords: patients critical; outcomes patients; limb; group ... See more keywords
Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Endovascular Therapy"
DOI: 10.1177/1526602817705135
Abstract: Purpose: To determine whether diabetes mellitus has an independent impact on major limb outcomes at 1 year after endovascular treatment of lower extremity peripheral artery disease (PAD). Methods: The study involved 1906 consecutive patients (mean… read more here.
Keywords: lower extremity; limb; limb outcomes; revascularization ... See more keywords